RGB-5088

N/A

Report date: 2026/01/29 15:47:11

Base Information

Drug NameRGB-5088
Drug Alias NameRGB-5088RGB5088
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionPancreatic beta cell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHangzhou Reprogenix Bioscience Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesHangzhou Reprogenix Bioscience Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A